Product
omaveloxolone
Aliases
RTA 408, RTA 408 Capsules
3 clinical trials
4 indications
Indication
RelapsedIndication
MelanomaIndication
HealthyClinical trial
An Open-Label, Single-Center, Dose-Escalation, Phase 1 Study of the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RTA 408 in the Treatment of Patients With Advanced Solid TumorsStatus: Completed, Estimated PCD: 2015-10-01
Clinical trial
A Phase 1, Open-Label, Food Effect, And Dose Proportionality Study With Omaveloxolone In Healthy VolunteersStatus: Completed, Estimated PCD: 2018-11-20